Mostrando 10 resultados de: 19
Filtros aplicados
Publisher
Clinical Rheumatology(4)
Journal of Clinical Rheumatology(3)
Autoimmunity Reviews(2)
Clinical Reviews in Allergy and Immunology(2)
Annals of the Rheumatic Diseases(1)
Área temáticas
Farmacología y terapéutica(11)
Medicina y salud(9)
Cirugía y especialidades médicas afines(1)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Medicina interna(8)
Inmunología(4)
Obstetricia(2)
Cuidado de la salud(1)
Medicamento(1)
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline predictors of remission and low disease activity (LDA) in early rhePalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusCorrection to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusCurrent therapies in rheumatoid arthritis: A Latin American perspective
OtherAbstract: Rheumatoid arthritis (RA) is a systemic inflammatory disease affecting the synovium of joints, tendoPalabras claves:Biologic therapy, Latin America, practice guidelines, Rheumatoid Arthritis, Socioeconomic factorsAutores:Burgos-Vargas R., Cardiel M.H., Catoggio L.J., Claudio M. Galarza-Maldonado, Ostojich K.Fuentes:scopusEarly rheumatoid arthritis in Latin America: Low socioeconomic status related to high disease activity at baseline
ArticleAbstract: Objective To determine the influence of socioeconomic factors on disease activity in a Latin AmericaPalabras claves:Autores:Acevedo-Vásquez E.M., Achurra-Castillo A.F., Caballero-Uribe C.V., Cardiel M.H., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Furst D.E., Guibert-Toledano Z.M., Hernández J.A., Laurindo I.M., Lino-Pérez L., Massardo L., Montufar R.A., Mota L.M.H., Padilla O., Pineda-Villaseñor C., Pons-Estel B.A., Ramírez L.A., Sacnun M.P., Soriano E.R., Wojdyla D.Fuentes:scopusDiagnosis and classification of rheumatoid arthritis
ArticleAbstract: Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease of unclear etiology that is manPalabras claves:Anti-cyclic citrullinated peptide (anti-CCP), Classification criteria, Rheumatoid Arthritis, Rheumatoid factorAutores:Claudio M. Galarza-Maldonado, Esteban Ortiz-Prado, Kourilovitch M.R.Fuentes:scopusFirst Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
ArticleAbstract: Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a sigPalabras claves:lupus nephritis, systemic lupus erythematosus, TreatmentAutores:Acevedo-Vásquez E.M., Acosta Colman M.I., Alarcón G.S., Alba Moreyra P.B., Alvarellos A.J., Amezcua-Guerra L.M., Amigo M.C., Appenzeller S., Aquino A.M., Arturi V., Babini A.M., Barile-Fabris L.A., Berbotto G.A., Betancur G.V., Bonfá E.S.D.D.O., Borba E.F., Brenol J.C.T., Burgos P.I., Cairoli E., Cardiel M.H., Cardoso Linhares F.A., Catoggio L.J., Cavalcanti A., Cavalcanti F.S., Chacón-DÍaz R., Cieza J., Claudio M. Galarza-Maldonado, Collado M.V., Conti S.M., Costallat L.T.L., Criniti J.M., Da Silva N.A., Danza A., Dos Reis Neto E.T., Drenkard C., Duarte M., Eraso Garnica R.M., Espada G., Fragoso-Loyo H.E., Fuentes-Silva Y.J., Gamboa-Cárdenas R.V., García de la Torre I., García M.A., García Valladares I., Gerling C., Gervasoni V.L., Gobbi C.A., Gómez-Martín D., Gómez-Puerta J.A., González Naranjo L.A., González-Bello Y.C., Gordon S., Guibert-Toledano M., Haye Salinas M.J., Herrera Uribe S., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Llanos C., Massardo L., Molina J.F., Montandon De Oliveira E Silva A.C., Monticielo O.A., Montúfar Guardado R.A., Mora-Trujillo C.S., Muñoz-Louis R., Neira O., Orozco M.C., Pera M.A., Pineda-Villaseñor C., Pons-Estel B.A., Pons-Estel G.J., Popoff F., Portela Hernández M., Quintana R.M., Retamozo S., Reyes G.L., Robaina Sevrini R., Rosario V., Sarano J., Sato E.I., Sattler M.E., Saurit V., Savio V., Scherbarth H.R., Scolnik M., Seguro L.P.C., Silva C.A., Silveira L.H., Soriano E.R., Ugarte-Gil M.F., Ugolini-Lopes M.R., Vargas Peña A., Vásquez G., Xavier R.M.Fuentes:scopusInfections and the antiphospholipid syndrome
ReviewAbstract: Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic predispositPalabras claves:Anticardiolipin, Antiphospholipid, infection, ThrombosisAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Mendoza-Pinto C.Fuentes:scopusThe HELLP syndrome, antiphospholipid antibodies, and syndromes
OtherAbstract:Palabras claves:Autores:Asherson R., Claudio M. Galarza-Maldonado, Sanin-Blair J.Fuentes:scopusThe administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus
ReviewAbstract: Background: In Latin America, the medical attention directed to systemic autoimmune diseases competePalabras claves:Autores:Cardiel M.H., Cervera R., Claudio M. Galarza-Maldonado, Doukh N., Kourilovitch M.R., Molineros J.E., Soroka N.F., Yagur V.Y., Zurita L.Fuentes:scopusNeurological manifestations of systemic lupus erythematosus: A comprehensive literature review
ReviewAbstract: Among autoimmune diseases, systemic lupus erythematosus (SLE) stands out. This disease is characteriPalabras claves:CNS, Neurologic complications, SLEAutores:Andrés López-Cortés, Claudio M. Galarza-Maldonado, Dayana Cuchiparte, Esteban Ortiz-Prado, Jorge Eduardo Vásconez, Katherine Peláez, Luis Leonardo Cano Cevallos, María Belén-LópezFuentes:googlescopus